Brice NL, Carlton M, Margolin DH, Bexon M, Matthews KL, Dawson LA, Ellenbogen AL, Olanow CW, Dubow J, Kieburtz K. CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial. EClinicalMedicine. 2024 Nov;77:102882. Epub 2024 Oct 18 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Solengepras